These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 12282921

  • 1. The clinical use of RU 486 (Mefipristone).
    Herrmann W.
    Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
    [Abstract] [Full Text] [Related]

  • 2. RU 486 (mifepristone): from clinical trials to the perspectives for clinical use.
    Elia D, Ulmann A.
    Contracept Fertil Sex (Paris); 1986 Dec; 14(12):1099-103. PubMed ID: 12314688
    [Abstract] [Full Text] [Related]

  • 3. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [Abstract] [Full Text] [Related]

  • 4. Antiprogestogens: from abortion to contraception.
    Prog Hum Reprod Res; 1992 May; (22):6-7. PubMed ID: 12286013
    [Abstract] [Full Text] [Related]

  • 5. Uses of RU 486: a clinical update.
    Elia D.
    IPPF Med Bull; 1986 Oct; 20(5):1-2. PubMed ID: 12341333
    [Abstract] [Full Text] [Related]

  • 6. [A new antiprogestational compound, mifepristone (RU-486)].
    Parisi C, Steffe M.
    Patol Clin Ostet Ginecol; 1988 Oct; 16(4):291-4. PubMed ID: 12345008
    [Abstract] [Full Text] [Related]

  • 7. [Clinical trial of pregnancy terminations in 353 patients where amenorrhea was present for less than 49 days by 600 mg of RU 486 (administered orally) and 500 mg of sulprostone (Nalador) administered intramuscularly].
    Aubeny E, Bureau A, Gabeaud P, Heard I, Eucher M, Husson T, Meng L, Riotte S.
    Fertil Contracept Sex; 1989 Apr; 17(4):307-14. PubMed ID: 12282175
    [Abstract] [Full Text] [Related]

  • 8. Abortion. Is RU 486/PG in its current form likely to be appropriate for women in Bangladesh?
    Kabir S, Germain A.
    Newsl Womens Glob Netw Reprod Rights; 1992 Apr; (38):39-45. PubMed ID: 12285435
    [Abstract] [Full Text] [Related]

  • 9. Looking into the future.
    Potts M.
    Plan Parent Rev; 1983 Apr; 3(2):3-5. PubMed ID: 12265636
    [Abstract] [Full Text] [Related]

  • 10. Life after Roe v. Wade.
    Bauerlein M.
    Utne Read; 1992 Apr; ():17-20. PubMed ID: 12343822
    [Abstract] [Full Text] [Related]

  • 11. [Application of anti-progesterone agents for contraception].
    Taketani Y, Mizuno M.
    Rinsho Fujinka Sanka; 1988 Apr; 42(11):997-1000. PubMed ID: 12283954
    [Abstract] [Full Text] [Related]

  • 12. Antiprogesterones.
    Norman J.
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [Abstract] [Full Text] [Related]

  • 13. RU-486: the experience of users.
    Girault-laurence J.
    Plan Parent Eur; 1991 Sep; 20(2):21. PubMed ID: 12284549
    [Abstract] [Full Text] [Related]

  • 14. RU-486 hits snags in U.K.
    Diconsiglio JM.
    Family Plan World; 1992 Sep; 2(1):1, 5. PubMed ID: 12317119
    [Abstract] [Full Text] [Related]

  • 15. Fertility control in women: results with RU 486 by the end of 1985.
    Baulieu E.
    J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366
    [Abstract] [Full Text] [Related]

  • 16. [RU 486 (mifepristone): a new tool for labor induction women at term with live fetus].
    Frydman R, Taylor S, Paoli C, Pourade A.
    Contracept Fertil Sex (Paris); 1992 Dec; 20(12):1133-6. PubMed ID: 12344709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    Couzinet B, Le Strat N, Ulmann A, Baulieu EE, Schaison G.
    N Engl J Med; 1986 Dec 18; 315(25):1565-70. PubMed ID: 3785321
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contraceptive technologies: how much choice do we really have?
    Fishel J.
    ZPG Report; 1997 Dec 18; 29(2):4-6. PubMed ID: 12293118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.